Clinical Trial Update: Combination of Chemotherapy and Adaptive MR-Guided Radiotherapy to Improve Outcomes in Patients With Esophageal Adenocarcinoma [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing the combination of chemotherapy and adaptive MR-guided radiotherapy for esophageal adenocarcinoma and gastroesophageal junction adenoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: UMC Utrecht | Conditions: Esophageal Adenocarcinoma, Esophageal Adenocarcinoma (EAC) | Phase 1 | Status: RECRUITING